AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3979761
Drug: Clear liquid
RxNorm normalized name: Ensure Clear Liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clear liquid diet with evening-laxative and morning-enema regimen
Trial: 21367884
Drug: Germinated barley
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Germinated barley foodstuff (GBF), 30 g daily for two months along with standard drug therapy
Trial: 28233343
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment groups (Computerized brain fitness exercise and Memory support system)
Trial: 25909969
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of oxytocin (30 IU in 0.9% normal saline/500 ml)
Trial: 9574640
Drug: 5% albumin
RxNorm normalized name: Flexbumin 5% Albumin (Human) Solution for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% albumin solution (hypervolemia group, n = 19)
Trial: 9574640
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline solution + 5% albumin solution (normovolemia group, n = 24)
Trial: 9574640
Drug: 5% albumin
RxNorm normalized name: Flexbumin 5% Albumin (Human) Solution for Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% albumin solution (hypervolemia group)
Trial: 2971597
Drug: CAF plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CAF plus Provera 200 mg daily for 3 weeks followed cyclically by Tamoxifen 20 mg daily for 3 weeks
Trial: 20523113
Drug: HB‐AS02 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HB‐AS02 vaccine (0 and 1 month)
Trial: 9504193
Drug: Lysine Clonixinate
RxNorm normalized name: lysine clonixinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lysine Clonixinate (LC) 125 mg
Trial: 9504193
Drug: Paracetamol 500
RxNorm normalized name: Paracetamol 500 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 500 mg + Codeine 30 mg
Trial: 8306757
Drug: 22-mg transdermal
RxNorm normalized name: methylphenidate 2.22 MG/HR Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 22-mg transdermal nicotine therapy with group counseling for 8 weeks (study 1)
Trial: 8306757
Drug: 22-mg transdermal
RxNorm normalized name: methylphenidate 2.22 MG/HR Transdermal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 22-mg transdermal nicotine therapy for 4 weeks followed by 11-mg for 2 weeks with brief individual counseling (study 2)
Trial: 29847967
Drug: Intranasal saline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal saline, intravenous saline and propofol (group P)
Trial: 29847967
Drug: Intranasal saline,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal saline, intravenous sulfentanil and propofol (group SP)
Trial: 18566196
Drug: Gabapentin 1200
RxNorm normalized name: Gabapentin
DrugBank: Gabapentin (DB00996)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gabapentin 1200 mg po (Group G)
Trial: 12757969
Drug: Desipramine (DMI)
DrugBank: Desipramine (DB01151)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desipramine (DMI) 150 mg/day
Trial: 10680303
Drug: Esmolol (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esmolol (500 micrograms/kg loading dose followed by 100 micrograms/kg/h infusion)
Trial: 10680303
Drug: Diltiazem (0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem (0.15 mg/kg loading dose followed by 5 mg/h infusion)
Trial: 1817959
Drug: Lamotrigine (100,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lamotrigine (100, 200, and 300 mg/day, b.i.d. regimen)
Trial: 29510699
Drug: Physically active
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physically active academic lessons (2 x 45 minutes weekly for 10 months)
Trial: 26933094
Drug: Oral opioid
RxNorm normalized name: OPIOIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral opioid treatment
Trial: 23190932
Drug: Functional exercise
RxNorm normalized name: plasma protein fraction Injection [Plasmanate]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional exercise class (twice weekly for six weeks from week 12 to week 18 post surgery) supervised by a chartered Physiotherapist
Trial: 20709000
Drug: Conventional TIV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional TIV (15 μg HA per strain)
Trial: 16382423
Drug: Culturally adapted
RxNorm normalized name: casein, emmental cultured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Culturally adapted cognitive-behavior therapy (IT condition)
Trial: 2375815
Drug: Intravenous fluids
RxNorm normalized name: amniotic fluid (bovine)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous fluids (Ringer's Lactate and a solution of 56 mEq/L of Na)
Trial: 199129
Drug: Fluphenazine decanoate
RxNorm normalized name: Fluphenazine Decanoate
DrugBank: Fluphenazine (DB00623)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluphenazine decanoate and oral fluphenazine
Trial: 31449932
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (2 weeks of free nicotine patches and referral to an outpatient smoking-cessation program)
Trial: 22332549
Drug: Fentanyl (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (100 microg initial dose, adjusted by 5 microg intervals) with 0.0625% W/V bupivacaine
Trial: 19565824
Drug: Sodium levothyroxin
RxNorm normalized name: Levothyroxine Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium levothyroxin and standard hypotensive therapy with ACE inhibitors
Trial: 17014518
Drug: Thrice‐weekly hemodialysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thrice‐weekly hemodialysis (4 hr for 4 weeks)
Trial: 15486373
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (ICS) - triamcinolone acetonide (1200 microg daily)
Trial: 3113599
Drug: Schwartz strain
RxNorm normalized name: Live attenuated measles virus (Schwartz strain)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Schwartz strain live measles vaccine
Trial: 10893282
Drug: Daily filgrastim
RxNorm normalized name: Filgrastim
DrugBank: Filgrastim (DB00099)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Daily filgrastim (5 microg/kg/d)
Trial: 1388334
Drug: Active medication
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active medication in patients without melancholia (76 patients)
Trial: 3903068
Drug: Aspirin/dipyridamole combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin/dipyridamole combination
Trial: 3550026
Drug: Conditioning therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conditioning therapy (n = 66)
Trial: 23886632
Drug: Clopidogrel (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (300 mg loading dose followed by 75 mg/day)
Trial: 18498993
Drug: Mitomycin-C (MMC)
DrugBank: Mitomycin (DB00305)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mitomycin-C (MMC) 0.02% (0.2 mg/mL)
Trial: 16256250
Drug: Zinc supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc supplementation (300 mg)
Trial: 12655320
Drug: Ethanol 1.4
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol 1.4 g/kg
Trial: 9113632
Drug: High-AA diet
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-AA diet (1.7 g/d of arachidonic acid for 50 d)
Trial: 3100859
Drug: Topical acyclovir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical acyclovir (ACV)
Trial: 18467303
Drug: Short-duration antimicrobial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short-duration antimicrobial treatment (5 days)
Trial: 8649628
Drug: Microemulsion formulation
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Microemulsion formulation of cyclosporin A
Trial: 28700781
Drug: High-dose spironolactone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose spironolactone (100 mg)
Trial: 28700781
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (placebo or 25 mg spironolactone)
Trial: 10658445
Drug: Reference group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference group (no treatment)
Trial: 22045829
Drug: tesaglitazar 2
RxNorm normalized name: Tesaglitazar
DrugBank: Tesaglitazar (DB06536)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tesaglitazar 2 mg
Trial: 17166340
Drug: pioglitazone 45
RxNorm normalized name: pioglitazone 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pioglitazone 45 mg
Trial: 22045829
Drug: tesaglitazar 2
RxNorm normalized name: Tesaglitazar
DrugBank: Tesaglitazar (DB06536)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: tesaglitazar 2 mg with ACE inhibitor
Trial: 8150535
Drug: Radical cystectomy
RxNorm normalized name: Campsis radicans flower extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radical cystectomy and pelvic-node dissection followed by adjuvant cisplatinum chemotherapy
Trial: 25731690
Drug: Vaginal progesterone
RxNorm normalized name: progesterone Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal progesterone (200 mg daily) until 34 weeks and 6 days' gestation
Trial: 21945107
Drug: Whole-pelvis concurrent
RxNorm normalized name: Sus scrofa renal pelvis preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole-pelvis concurrent chemoradiation (WP-CCRT)
Trial: 21945107
Drug: Bladder-only concurrent
RxNorm normalized name: Sus scrofa urinary bladder preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bladder-only concurrent chemoradiation (BO-CCRT)
Trial: 17469099
Drug: Methotrexate (MTX)
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate (MTX) 15 mg/week, increased every 3 months if Disease Activity Score >2.4, tapered after 12 months
Trial: 2193629
Drug: Thalidomide 100
RxNorm normalized name: thalidomide 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide 100 mg/d
Trial: 15262695
Drug: Thalidomide 100
RxNorm normalized name: thalidomide 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thalidomide 100 or 200 mg/d (after randomization)
Trial: 15136218
Drug: Thalidomide treatment
RxNorm normalized name: Thalidomide
DrugBank: Thalidomide (DB01041)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Thalidomide treatment
Trial: 17426158
Drug: Chloroquine (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (25 mg/kg)
Trial: 12225503
Drug: Chloroquine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (40 mg/kg)
Trial: 12225503
Drug: Sulfadoxine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine (500 mg) and Pyrimethamine (25 mg)
Trial: 12225503
Drug: Quinine (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinine (30 mg/kg)
Trial: 9308538
Drug: implants not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: implants not removed
Trial: 7213519
Drug: Spironolactone 25,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 25, 50, 100 and 200 mg daily
Trial: 29063827
Drug: Adalimumab injections
RxNorm normalized name: Adalimumab
DrugBank: Adalimumab (DB00051)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Adalimumab injections (80 mg and then 40 mg 2 weeks later) plus physiotherapy
Trial: 25524507
Drug: Fluticasone furoate/vilanterol
RxNorm normalized name: fluticasone furoate/vilanterol 100/25 MCG/INHAL Dry Powder Inhaler, 30 Blisters
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluticasone furoate/vilanterol (FF/VI) 200/25 mcg
Trial: 25524507
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 500 mcg
Trial: 19289172
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg caffeine
Trial: 21975110
Drug: Prolonged-release melatonin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release melatonin (Circadin®) 2 mg daily
Trial: 18669576
Drug: Budesonide 6
RxNorm normalized name: budesonide 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 6 mg/day
Trial: 11156722
Drug: Tirofiban (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tirofiban (0.1 microg/kg/min intravenously) + Unfractionated heparin (intravenous, adjusted to activated partial thromboplastin time)
Trial: 9660035
Drug: Placebo daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo daily for 28 days prior to zolmitriptan administration
Trial: 9660035
Drug: Zolmitriptan 10
RxNorm normalized name: zolmitriptan 100 % MISCELL POWDER (GRAM)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zolmitriptan 10 mg oral dose
Trial: 9660035
Drug: Zolmitriptan alone
RxNorm normalized name: Zolmitriptan
DrugBank: Zolmitriptan (DB00315)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zolmitriptan alone or with fluoxetine
Trial: 50126
Drug: Bleomycin via
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bleomycin via continuous infusion
Trial: 31628043
Drug: Nintedanib 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nintedanib 200 mg twice daily plus best supportive care
Trial: 23525448
Drug: PSI-697 600
RxNorm normalized name: psi-Norephedrine
DrugBank: Cathine (DB01486)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PSI-697 600 mg
Trial: 23525448
Drug: P-selectin-blocking antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: P-selectin-blocking antibody (CLB-Thromb6)
Trial: 10681341
Drug: Regimen A
RxNorm normalized name: CHLOROXYLENOL 5 g in 1000 mL TOPICAL SOAP [REGIMEN ANTIMICROBIAL]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen A (1,920 mg over 3 days, four doses)
Trial: 10681341
Drug: Regimen B
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen B (2,780 mg over 3 days, six doses)
Trial: 10681341
Drug: Regimen C
RxNorm normalized name: ASPIRIN 81 mg ORAL TABLET, CHEWABLE [Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regimen C (2,780 mg over 5 days, six doses)
Trial: 10681341
Drug: Normal meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal meal close to drug administration
Trial: 10681341
Drug: Higher-dose regimens
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-dose regimens (B and C)
Trial: 28774461
Drug: Bevacizumab (15mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bevacizumab (15mg/kg every 3 weeks) with carboplatin (AUC 5) and weekly paclitaxel (80mg/m2) for at least 6 cycles
Trial: 25376448
Drug: Etanercept (ETN)
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept (ETN) 50 mg QW for 12 weeks followed by 50 mg QW for 12 weeks
Trial: 25376448
Drug: Etanercept (ETN)
RxNorm normalized name: Etanercept
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Etanercept (ETN) 50 mg BIW/QW
Trial: 22743849
Drug: Radiofrequency treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiofrequency treatment (RFT) of the soft palate
Trial: 16873594
Drug: Face-to-face motivational
RxNorm normalized name: FACE SHIELD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Face-to-face motivational interviewing plus telephone counseling and offering of medication
Trial: 31344434
Drug: Patients whose
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients whose pain improved after palliative radiation therapy
Trial: 31344434
Drug: Single fraction
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single fraction palliative radiation therapy (8 Gy) including reirradiation
Trial: 31344434
Drug: Fractionated palliative
RxNorm normalized name: LIVER FRACTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fractionated palliative radiation therapy (24 Gy in 6 fractions) including reirradiation
Trial: 30104895
Drug: Ozone Injection
RxNorm normalized name: ozone
DrugBank: Ozone (DB12510)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ozone Injection Group (OZG) - 6 mL of ozone 30 µg/mL injected into the center of the disc
Trial: 27434505
Drug: Buprenorphine buccal
RxNorm normalized name: buprenorphine Buccal Film
DrugBank: Buprenorphine (DB00921)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Buprenorphine buccal film (BBUP)
Trial: 21034888
Drug: Peptide-based formula
RxNorm normalized name: peptide-T
DrugBank: Peptide-T (DB19279)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peptide-based formula with 3.5 g fructo-oligosaccharides and 3.8 g insoluble fiber/L
Trial: 31909887
Drug: 5 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg/day isoniazid (INH)
Trial: 31909887
Drug: 10 mg/kg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg/day isoniazid (INH)
Trial: 28461159
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (200,000 IU initial dose followed by 100,000 IU monthly)
Trial: 26823746
Drug: Low volume
RxNorm normalized name: CONNECTOR,LOW VOLUME,ENFIT MOOG INFINITY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low volume of 7 ml/kg IBW with 8 cm H2O PEEP and recruitment
Trial: 26823746
Drug: Low volume
RxNorm normalized name: CONNECTOR,LOW VOLUME,ENFIT MOOG INFINITY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low volume of 7 ml/kg IBW with 8 cm H2O PEEP
Trial: 26823746
Drug: High volume
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High volume of 9 ml/kg IBW with ZEEP
Trial: 17295604
Drug: Anakinra (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anakinra (100 mg/d)
Trial: 17295604
Drug: Etanercept (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etanercept (25 mg/twice weekly)
Trial: 15114301
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (Certoparin 3000 IU subcutaneously)
Trial: 20646562
Drug: Patient-controlled epidural
RxNorm normalized name: epidermal growth factor
DrugBank: Nepidermin (DB14145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled epidural analgesia (PCEA) without low molecular heparin (LMWH)
Trial: 20646562
Drug: Patient-controlled intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled intravenous analgesia (PCIA) without low molecular heparin (LMWH)
Trial: 20646562
Drug: Patient-controlled intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patient-controlled intravenous analgesia (PCIA) combined with low molecular heparin (LMWH)
Trial: 18653492
Drug: Sugammadex (2.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sugammadex (2.0 mg kg(‐1)) administered at reappearance of the second twitch of the TOF.
Trial: 10997756
Drug: Ventricular resynchronization
RxNorm normalized name: DRESSING,VENTRICULAR ASSIST DEVICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ventricular resynchronization therapy alone
Trial: 10997756
Drug: Ventricular resynchronization
RxNorm normalized name: DRESSING,VENTRICULAR ASSIST DEVICE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ventricular resynchronization therapy combined with cardioverter-defibrillator capability
Trial: 10997756
Drug: Optimal pharmacological
RxNorm normalized name: Optima Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Optimal pharmacological therapy alone
Trial: 393076
Drug: Alcohol 0.8
RxNorm normalized name: isopropyl alcohol 0.8 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol 0.8 g/kg
Trial: 3734141
Drug: Buspirone and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buspirone and Diazepam pharmacokinetics
Trial: 3734141
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of buspirone
Trial: 29473354
Drug: Routine western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine western medicine with intravenous drip of ulinastatin (Control group).
Trial: 26816234
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day of Physta® standardized root water extract of Eurycoma longifolia (Tongkat Ali) for 4 weeks
Trial: 18720881
Drug: Desloratadine and
RxNorm normalized name: Desloratadine and pseudoephedrine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine and normal sodium spray
Trial: 18720881
Drug: Desloratadine and
RxNorm normalized name: Desloratadine and pseudoephedrine only product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desloratadine and Nasonex spray
Trial: 18720881
Drug: Placebo and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo and normal sodium spray
Trial: 15820828
Drug: Vaginal bromocriptine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal bromocriptine suppositories with Pluronic F127
Trial: 15820828
Drug: Vaginal application
RxNorm normalized name: Vaginal Insert
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaginal application of bromocriptine tablets
Trial: 24703170
Drug: Adjunctive medroxyprogesterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive medroxyprogesterone acetate (MPA)
Trial: 15983278
Drug: Housing contingent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Housing contingent on drug abstinence (ACH)
Trial: 9467047
Drug: Granisetron (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron (10 micrograms/kg) administered as a 30-second intravenous bolus infusion